Digital Health Podcasts

Podcasts

Digital

pharmaphorum podcast Episode 261 - Kris Kaneta, Norstella

Trustworthy and novel AI in clinical trial planning, with Kr...

Norstella's Kris Kaneta discusses why patient-level data is pharma's most important asset, as well as expanding the efficacy of AI for clinical trials

Digital

BIO-Europe Spring podcast with Kashif Sadiq

Creating what nature has not from AI and computational molec...

Kashif Sadiq, founder and CEO of DenovAI Biotech discusses harnessing the power of artificial intelligence and computational molecular biophysics.

Digital

BIO-Europe Spring interview with Dr Olga Nissan

On collaboration, computational chemistry, and cutting-edge ...

Dr Olga Nissan, vice president of business development at Evogene discusses collaboration with Google Cloud & generative design of small molecules.

Digital

pharmaphorum podcast Episode 242, Yann Gaston-Mathe, Iktos

JPM2026: Broadening AI drug discovery to include the lab, wi...

Yann Gaston-Mathe, founder and CEO of Iktos, discusses AI drug discovery's shift to real-world operations that are able to incorporate wet lab data.

Digital

pharmaphorum podcast Episode 240, Andrew Beck, PathAI

JPM2026: AI diagnostics and translational research, with And...

On the sidelines of JPM2026, pharmaphorum spoke with Andrew Beck, co-founder and CEO at PathAI, about AI diagnostics in pathology.

Digital

pharmaphorum podcast Episode 236, Tarek Samad, Lundbeck

An AI supercomputer and discovering next-gen brain disorder ...

Tarek Samad, Lundbeck’s senior vice president and head of research, discusses AI – specifically, Lundbeck’s agreement with the DCAI to operate Gefion.

Trustworthy and novel AI in clinical trial planning, with Kr...

Creating what nature has not from AI and computational molec...

On collaboration, computational chemistry, and cutting-edge ...

JPM2026: Broadening AI drug discovery to include the lab, wi...

JPM2026: AI diagnostics and translational research, with And...

An AI supercomputer and discovering next-gen brain disorder ...

Lilly strikes $1.9bn kidney disease alliance with Ascidian

Discover a new era of healthcare panel engagement: Grounded ...

Podcasts

Editor's Picks